Latest AI and machine learning research in other cancers for healthcare professionals.
Intrinsically disordered proteins (IDPs) and their involvement in liquid-liquid phase separation (LLPS) have reshaped our understanding of how cells organize biochemical reactions in space and time. Unlike structured proteins, IDPs populate highly dynamic conformational ensembles that promote weak, multivalent interactions and enable the formation of biomolecular condensates (BCs). When these phas...
OBJECTIVES: Studies have reported promising results regarding artificial intelligence (AI) as a tool for improved mammographic screening interpretive performance. We analyzed AI malignancy risk scores from two versions of the same commercial AI model. MATERIALS AND METHODS: This retrospective cohort study used data from 117,709 screening examinations performed in BreastScreen Norway 2009-2018. The...
BACKGROUND: The aim of this study was to identify and validate clinically meaningful predictors of local treatment failure (LTF) after stereotactic ra...
BACKGROUND: AI-enabled personalized treatment planning may improve outcomes by tailoring care, yet its clinical impact across modalities remains uncer...
BACKGROUND: Glioma is the most common malignant primary brain tumor. Temozolomide (TMZ) is the standard first-line chemotherapy, but its efficacy is s...
Chimeric antigen receptor T-cell (CAR-T) therapy has achieved unprecedented success in hematological malignancies but faces formidable challenges in s...
In recent years, Raman and Infrared spectroscopy have become important tools in disease diagnosis due to their high sensitivity and non-invasive detec...
BACKGROUND: Lung adenocarcinoma (LUAD) remains a major clinical challenge in assessment of clinical outcomes and therapeutic response. Although tumor-...
OBJECTIVE: To develop and validate an integrated model combining Gd-EOB-DTPA-enhanced MRI habitat imaging with clinical features for preoperative pred...
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy. Accurate prognostic modeling enables reliable risk stratification to identi...
BACKGROUND: Metastasis drives mortality in breast invasive carcinoma. We sought miRNA biomarkers that (i) discriminate metastatic potential, (ii) stra...
Ovarian cancer is one of the most lethal gynecological malignancies, asymptomatic early progression, ineffective screening, and high histological hete...
PURPOSE: This study aims to develop an artificial intelligence (AI) model to assist ophthalmologists in distinguishing ocular surface squamous neoplas...
BACKGROUND: Radiotherapy is a cornerstone in the treatment of brain metastases, but its mid- and long-term impact on brain parenchyma remains poorly u...
BACKGROUND: Alzheimer's disease (AD) is increasingly recognized as a multifactorial network disorder in which amyloid and tau pathology interact with ...
Determining molecular markers that mediate clinically aggressive phenotypes in prostate cancer is a significant challenge. While traditional linear mo...
PURPOSE: Small cell lung cancer (SCLC) is a highly aggressive malignancy with a high incidence of liver metastases, particularly among elderly patient...
Endoscopic ultrasound (EUS) has evolved from a diagnostic imaging tool into a versatile platform that enables high-precision access, sampling, and the...
BACKGROUND: Nurses are at the forefront of providing palliative care, playing a critical role in ensuring high-quality support for patients and their ...
BACKGROUND: Despite affecting approximately 30% of the population, the pathogenesis of temporomandibular disorders (TMD) remains poorly understood. Co...